世界の注射用抗凝固剤市場:成長動向・競争分析2020-2026

【英語タイトル】Global Injectable Anticoagulants Industry Research Report, Growth Trends and Competitive Analysis 2020-2026

QYResearchが出版した調査資料(QYR20AP01120)・商品コード:QYR20AP01120
・発行会社(調査会社):QYResearch
・発行日:2020年3月20日(※2024年版があります。お問い合わせください)
・ページ数:116
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥725,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,087,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,450,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
当リサーチレポートでは、注射用抗凝固剤の世界市場規模が2019年xx百万ドルから2026年xx百万ドルまで年平均xx%成長すると予測しています。当レポートは、注射用抗凝固剤のグローバル市場動向、メーカー別競争状況、種類別市場規模(低分子ヘパリン(LMWH)、直接トロンビン阻害剤(DTI)、その他)、用途別市場規模(VTE、ACS/MI、AF、その他)、北米市場、アジア市場、中南米市場、中東・アフリカ市場分析、関連企業情報、サプライチェーン、販売チャネル分析、地域別市場規模予測データなどを掲載しています。

・レポート概要
・グローバル市場動向
・メーカー別競争状況
・注射用抗凝固剤の種類別市場2015-2026:低分子ヘパリン(LMWH)、直接トロンビン阻害剤(DTI)、その他
・注射用抗凝固剤の用途別市場2015-2026:VTE、ACS/MI、AF、その他
・注射用抗凝固剤の北米市場分析
・注射用抗凝固剤のアジア市場分析
・注射用抗凝固剤の中南米市場分析
・注射用抗凝固剤の中東・アフリカ市場分析
・関連企業情報:Sanofi、Genentech (Roche)、Boehringer Ingelheim、Pfizer、The Medicines Company、Aspen、Otsuka
・サプライチェーン及び販売チャネル分析
・地域別市場規模予測2021-2026:北米、ヨーロッパ、アジア、中南米、中東・アフリカ
・結論
【レポートの概要】

The injectable anticoagulants include low molecular weight heparin (LMWH) agents (dalteparin [Fragmin®], enoxaparin [Lovenox®]) and factor Xa inhibitors (fondaparinux [Arixtra®]).In the last several years, global market of injectable anticoagulants developed slowly. In 2016, global revenue of injectable anticoagulants is nearly 5300 M USD. And the global growth rate is slow.
In 2019, the global Injectable Anticoagulants market size was US$ 5814.9 million and is forecast to US$ 7070.3 million in 2026, growing at a CAGR of 2.8% from 2020. In this study, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for Injectable Anticoagulants.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Injectable Anticoagulants market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Injectable Anticoagulants market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Injectable Anticoagulants market. Readers of the report can become informed about current and future trends of the global Injectable Anticoagulants market and how they will impact market growth during the forecast period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise and country-wise Injectable Anticoagulants markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E etc.
For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Injectable Anticoagulants market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.
Market Segmentation by Type and by Application
The report includes a detailed analysis of leading and by Type and by Application segments of the global Injectable Anticoagulants market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue, sales analysis and forecast of the global Injectable Anticoagulants market by Type and by Application segment for the period 2015-2026.

Market Segment by Type, the Injectable Anticoagulants market is segmented into
Low-molecular-weight Heparin (LMWH)
Direct Thrombin Inhibitor (DTI)
Other

Market Segment by Application, the Injectable Anticoagulants market is segmented into
VTE
ACS/MI
AF
Other

This report includes the following manufacturers; we can also add the other companies as you want.
Sanofi
Genentech (Roche)
Boehringer Ingelheim
Pfizer
The Medicines Company
Aspen
Otsuka

The study objectives are:
To analyze and research the global Injectable Anticoagulants status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Injectable Anticoagulants manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Injectable Anticoagulants are as follows:
History Year: 2015-2020
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Top Injectable Anticoagulants Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Injectable Anticoagulants Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 Low-molecular-weight Heparin (LMWH)
1.3.3 Direct Thrombin Inhibitor (DTI)
1.3.4 Other
1.4 Market Segment by Application
1.4.1 Global Injectable Anticoagulants Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 VTE
1.4.3 ACS/MI
1.4.4 AF
1.4.5 Other
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Injectable Anticoagulants Revenue (2015-2026)
2.1.1 Global Injectable Anticoagulants Revenue (2015-2026)
2.1.2 Global Injectable Anticoagulants Sales (2015-2026)
2.2 Injectable Anticoagulants Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Injectable Anticoagulants Sales by Regions (2015-2020)
2.2.2 Global Injectable Anticoagulants Revenue by Regions (2015-2020)
2.3 Global Top Injectable Anticoagulants Regions (Countries) Ranking by Market Size
2.4 Injectable Anticoagulants Industry Trends
2.4.1 Injectable Anticoagulants Market Top Trends
2.4.2 Market Drivers
2.4.3 Injectable Anticoagulants Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key Injectable Anticoagulants Players: Views for Future

3 Competitive Landscape by Manufacturers
3.1 Global Top Injectable Anticoagulants Manufacturers by Sales (2015-2020)
3.1.1 Global Injectable Anticoagulants Sales by Manufacturers (2015-2020)
3.1.2 Global Injectable Anticoagulants Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Injectable Anticoagulants Sales in 2019
3.2 Global Top Manufacturers Injectable Anticoagulants by Revenue
3.2.1 Global Injectable Anticoagulants Revenue by Manufacturers (2015-2020)
3.2.2 Global Injectable Anticoagulants Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Injectable Anticoagulants Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Injectable Anticoagulants as of 2019)
3.4 Global Injectable Anticoagulants Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Injectable Anticoagulants Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Injectable Anticoagulants Market
3.7 Key Manufacturers Injectable Anticoagulants Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Injectable Anticoagulants Historic Market Review by Type (2015-2020)
4.1.2 Global Injectable Anticoagulants Sales Market Share by Type (2015-2020)
4.1.3 Global Injectable Anticoagulants Revenue Market Share by Type (2015-2020)
4.1.4 Injectable Anticoagulants Price by Type (2015-2020)
4.1 Global Injectable Anticoagulants Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Injectable Anticoagulants Sales Forecast by Type (2021-2026)
4.2.3 Global Injectable Anticoagulants Revenue Forecast by Type (2021-2026)
4.2.4 Injectable Anticoagulants Price Forecast by Type (2021-2026)

5 Global Injectable Anticoagulants Market Size by Application
5.1 Global Injectable Anticoagulants Historic Market Review by Application (2015-2020)
5.1.2 Global Injectable Anticoagulants Sales Market Share by Application (2015-2020)
5.1.3 Global Injectable Anticoagulants Revenue Market Share by Application (2015-2020)
5.1.4 Injectable Anticoagulants Price by Application (2015-2020)
5.2 Global Injectable Anticoagulants Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Injectable Anticoagulants Sales Forecast by Application (2021-2026)
5.2.3 Global Injectable Anticoagulants Revenue Forecast by Application (2021-2026)
5.2.4 Injectable Anticoagulants Price Forecast by Application (2021-2026)

6 North America
6.1 North America Injectable Anticoagulants Breakdown Data by Company
6.2 North America Injectable Anticoagulants Breakdown Data by Type
6.3 North America Injectable Anticoagulants Breakdown Data by Application
6.4 North America Injectable Anticoagulants Breakdown Data by Countries
6.4.1 North America Injectable Anticoagulants Sales by Countries
6.4.2 North America Injectable Anticoagulants Revenue by Countries
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe Injectable Anticoagulants Breakdown Data by Company
7.2 Europe Injectable Anticoagulants Breakdown Data by Type
7.3 Europe Injectable Anticoagulants Breakdown Data by Application
7.4 Europe Injectable Anticoagulants Breakdown Data by Countries
7.4.1 Europe Injectable Anticoagulants Sales by Countries
7.4.2 Europe Injectable Anticoagulants Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Injectable Anticoagulants Breakdown Data by Company
8.2 Asia Pacific Injectable Anticoagulants Breakdown Data by Type
8.3 Asia Pacific Injectable Anticoagulants Breakdown Data by Application
8.4 Asia Pacific Injectable Anticoagulants Breakdown Data by Regions
8.4.1 Asia Pacific Injectable Anticoagulants Sales by Regions
8.4.2 Asia Pacific Injectable Anticoagulants Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America Injectable Anticoagulants Breakdown Data by Company
9.2 Latin America Injectable Anticoagulants Breakdown Data by Type
9.3 Latin America Injectable Anticoagulants Breakdown Data by Application
9.4 Latin America Injectable Anticoagulants Breakdown Data by Countries
9.4.1 Latin America Injectable Anticoagulants Sales by Countries
9.4.2 Latin America Injectable Anticoagulants Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Injectable Anticoagulants Breakdown Data by Type
10.2 Middle East and Africa Injectable Anticoagulants Breakdown Data by Application
10.3 Middle East and Africa Injectable Anticoagulants Breakdown Data by Countries
10.3.1 Middle East and Africa Injectable Anticoagulants Sales by Countries
10.3.2 Middle East and Africa Injectable Anticoagulants Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E

11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Business Overview and Total Revenue (2019 VS 2018)
11.1.3 Sanofi Injectable Anticoagulants Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 Sanofi Injectable Anticoagulants Products and Services
11.1.5 Sanofi SWOT Analysis
11.1.6 Sanofi Recent Developments
11.2 Genentech (Roche)
11.2.1 Genentech (Roche) Corporation Information
11.2.2 Genentech (Roche) Business Overview and Total Revenue (2019 VS 2018)
11.2.3 Genentech (Roche) Injectable Anticoagulants Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.2.4 Genentech (Roche) Injectable Anticoagulants Products and Services
11.2.5 Genentech (Roche) SWOT Analysis
11.2.6 Genentech (Roche) Recent Developments
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Corporation Information
11.3.2 Boehringer Ingelheim Business Overview and Total Revenue (2019 VS 2018)
11.3.3 Boehringer Ingelheim Injectable Anticoagulants Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.3.4 Boehringer Ingelheim Injectable Anticoagulants Products and Services
11.3.5 Boehringer Ingelheim SWOT Analysis
11.3.6 Boehringer Ingelheim Recent Developments
11.4 Pfizer
11.4.1 Pfizer Corporation Information
11.4.2 Pfizer Business Overview and Total Revenue (2019 VS 2018)
11.4.3 Pfizer Injectable Anticoagulants Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.4.4 Pfizer Injectable Anticoagulants Products and Services
11.4.5 Pfizer SWOT Analysis
11.4.6 Pfizer Recent Developments
11.5 The Medicines Company
11.5.1 The Medicines Company Corporation Information
11.5.2 The Medicines Company Business Overview and Total Revenue (2019 VS 2018)
11.5.3 The Medicines Company Injectable Anticoagulants Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.5.4 The Medicines Company Injectable Anticoagulants Products and Services
11.5.5 The Medicines Company SWOT Analysis
11.5.6 The Medicines Company Recent Developments
11.6 Aspen
11.6.1 Aspen Corporation Information
11.6.2 Aspen Business Overview and Total Revenue (2019 VS 2018)
11.6.3 Aspen Injectable Anticoagulants Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.6.4 Aspen Injectable Anticoagulants Products and Services
11.6.5 Aspen SWOT Analysis
11.6.6 Aspen Recent Developments
11.7 Otsuka
11.7.1 Otsuka Corporation Information
11.7.2 Otsuka Business Overview and Total Revenue (2019 VS 2018)
11.7.3 Otsuka Injectable Anticoagulants Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.7.4 Otsuka Injectable Anticoagulants Products and Services
11.7.5 Otsuka SWOT Analysis
11.7.6 Otsuka Recent Developments

12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Injectable Anticoagulants Sales Channels
12.2.2 Injectable Anticoagulants Distributors
12.3 Injectable Anticoagulants Customers

13 Estimates and Projections by Regions (2021-2026)
13.1 Global Injectable Anticoagulants Sales Forecast (2021-2026)
13.1.1 Global Injectable Anticoagulants Sales Forecast by Regions (2021-2026)
13.1.2 Global Injectable Anticoagulants Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Injectable Anticoagulants Sales Forecast (2021-2026)
13.2.2 North America Injectable Anticoagulants Revenue Forecast (2021-2026)
13.2.3 North America Injectable Anticoagulants Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Injectable Anticoagulants Sales Forecast (2021-2026)
13.3.2 Europe Injectable Anticoagulants Revenue Forecast (2021-2026)
13.3.3 Europe Injectable Anticoagulants Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Injectable Anticoagulants Sales Forecast (2021-2026)
13.4.2 Asia Pacific Injectable Anticoagulants Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Injectable Anticoagulants Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Injectable Anticoagulants Sales Forecast (2021-2026)
13.5.2 Latin America Injectable Anticoagulants Revenue Forecast (2021-2026)
13.5.3 Latin America Injectable Anticoagulants Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Injectable Anticoagulants Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Injectable Anticoagulants Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Injectable Anticoagulants Size Forecast by County (2021-2026)

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Injectable Anticoagulants Key Market Segments
Table 2. Ranking of Global Top Injectable Anticoagulants Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Injectable Anticoagulants Market Size Growth Rate by Type 2021-2026 (K Units) & (Million US$)
Table 4. Major Manufacturers of Low-molecular-weight Heparin (LMWH)
Table 5. Major Manufacturers of Direct Thrombin Inhibitor (DTI)
Table 6. Major Manufacturers of Other
Table 7. Global Injectable Anticoagulants Market Share by Application 2019-2025 (K Units)
Table 8. Global Injectable Anticoagulants Market Size by Regions 2015-2020 (K Units) & (Million US$)
Table 9. Global Injectable Anticoagulants Sales by Regions 2015-2020 (K Units)
Table 10. Global Injectable Anticoagulants Sales Market Share by Regions 2015-2020
Table 11. Global Injectable Anticoagulants Revenue by Regions 2015-2020 (Million US$)
Table 12. Global Injectable Anticoagulants Revenue Market Share by Regions 2015-2020
Table 13. Top Injectable Anticoagulants Regions (Countries) Ranking by Market Size (US$ Million) in 2019
Table 14. Market Top Trends
Table 15. Injectable Anticoagulants Key Drivers: Impact Analysis (2021-2026)
Table 16. Injectable Anticoagulants Key Challenges
Table 17. Main Points Interviewed from Key Injectable Anticoagulants Players: Views for Future
Table 18. Global Injectable Anticoagulants Sales by Manufacturers (2015-2020) (K Units)
Table 19. Global Injectable Anticoagulants Sales Share by Manufacturers (2015-2020)
Table 20. Injectable Anticoagulants Revenue by Manufacturers (2015-2020) (Million US$)
Table 21. Injectable Anticoagulants Revenue Share by Manufacturers (2015-2020)
Table 22. Global Injectable Anticoagulants Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Injectable Anticoagulants as of 2019)
Table 24. Key Manufacturers Injectable Anticoagulants Average Selling Price (ASP) (2015-2020) (USD/Unit)
Table 25. Key Manufacturers Injectable Anticoagulants Plants/Factories Distribution
Table 26. Key Manufacturers Injectable Anticoagulants Area Served
Table 27. Date of Key Manufacturers Enter into Injectable Anticoagulants Market
Table 28. Key Manufacturers Injectable Anticoagulants Product Type
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Low-molecular-weight Heparin (LMWH) Sales and Revenue (2015-2020) (K Units) & (Million US$)
Table 31. Global Direct Thrombin Inhibitor (DTI) Sales and Revenue (2015-2020) (K Units) & (Million US$)
Table 32. Global Other Sales ana Revenue (2015-2020) (K Units) & (Million US$)
Table 33. Global Injectable Anticoagulants Sales (K Units) by Type (2015-2020)
Table 34. Global Injectable Anticoagulants Sales Share by Type (2015-2020)
Table 35. Global Injectable Anticoagulants Revenue (US$ Million) Market Share by Type (2015-2020)
Table 36. Global Injectable Anticoagulants Price (K Units) by Type (2015-2020)
Table 37. Global Injectable Anticoagulants Sales (K Units) by Type (2021-2026)
Table 38. Global Injectable Anticoagulants Sales Share by Type (2021-2026)
Table 39. Global Injectable Anticoagulants Revenue (US$ Million) Market Share by Type (2021-2026)
Table 40. Global Injectable Anticoagulants Revenue Share by Type (2021-2026)
Table 41. Global Injectable Anticoagulants Price (K Units) by Type (2021-2026)
Table 42. Global Injectable Anticoagulants Sales (K Units) by Application (2015-2020)
Table 43. Global Injectable Anticoagulants Sales Share by Application (2015-2020)
Table 44. Global Injectable Anticoagulants Revenue (US$ Million) Market Share by Application (2015-2020)
Table 45. Global Injectable Anticoagulants Price by Application 2015-2020 (USD/Unit)
Table 46. Global Injectable Anticoagulants Sales by Application (2015-2020) (K Units)
Table 47. Global Injectable Anticoagulants Sales Share by Application (2015-2020)
Table 48. Global Injectable Anticoagulants Revenue (US$ Million) Market Share by Application (2021-2026)
Table 49. Global Injectable Anticoagulants Revenue Share by Application (2021-2026)
Table 50. Global Injectable Anticoagulants Price (K Units) by Application (2021-2026)
Table 51. North America Injectable Anticoagulants Sales by Company (2015-2020) (K Units)
Table 52. North America Injectable Anticoagulants Sales Market Share by Company (2015-2020)
Table 53. North America Injectable Anticoagulants Sales by Type (2015-2020) (K Units)
Table 54. North America Injectable Anticoagulants Sales Market Share by Type (2015-2020)
Table 55. North America Injectable Anticoagulants Sales by Application (2015-2020) (K Units)
Table 56. North America Injectable Anticoagulants Sales Market Share by Application (2015-2020)
Table 57. North America Injectable Anticoagulants Sales by Countries (2015-2020) (K Units)
Table 58. North America Injectable Anticoagulants Sales Market Share by Countries (2015-2020)
Table 59. North America Injectable Anticoagulants Revenue by Countries (2015-2020) (Million US$)
Table 60. North America Injectable Anticoagulants Revenue Market Share by Countries (2015-2020)
Table 61. Europe Injectable Anticoagulants Sales by Company (2015-2020) (K Units)
Table 62. Europe Injectable Anticoagulants Sales Market Share by Company (2015-2020)
Table 63. Europe Injectable Anticoagulants Sales by Type (2015-2020) (K Units)
Table 64. Europe Injectable Anticoagulants Sales Market Share by Type (2015-2020)
Table 65. Europe Injectable Anticoagulants Sales by Application (2015-2020) (K Units)
Table 66. Europe Injectable Anticoagulants Sales Market Share by Application (2015-2020)
Table 67. Europe Injectable Anticoagulants Sales by Countries (2015-2020) (K Units)
Table 68. Europe Injectable Anticoagulants Sales Market Share by Countries (2015-2020)
Table 69. Europe Injectable Anticoagulants Revenue by Countries (2015-2020) (Million US$)
Table 70. Europe Injectable Anticoagulants Revenue Market Share by Countries (2015-2020)
Table 71. Asia Pacific Injectable Anticoagulants Sales by Regions (2015-2020) (K Units)
Table 72. Asia Pacific Injectable Anticoagulants Sales Market Share by Regions (2015-2020)
Table 73. Asia Pacific Injectable Anticoagulants Sales by Type (2015-2020) (K Units)
Table 74. Asia Pacific Injectable Anticoagulants Sales Market Share by Type (2015-2020)
Table 75. Asia Pacific Injectable Anticoagulants Sales by Application (2015-2020) (K Units)
Table 76. Asia Pacific Injectable Anticoagulants Sales Market Share by Application (2015-2020)
Table 77. Asia Pacific Injectable Anticoagulants Sales by Countries (2015-2020) (K Units)
Table 78. Asia Pacific Injectable Anticoagulants Sales Market Share by Regions (2015-2020)
Table 79. Asia Pacific Injectable Anticoagulants Revenue by Regions (2015-2020) (Million US$)
Table 80. Asia Pacific Injectable Anticoagulants Revenue Market Share by Regions (2015-2020)
Table 81. Latin America Injectable Anticoagulants Sales by Company (2015-2020) (K Units)
Table 82. Latin America Injectable Anticoagulants Sales Market Share by Company (2015-2020)
Table 83. Latin America Injectable Anticoagulants Sales by Type (2015-2020) (K Units)
Table 84. Latin America Injectable Anticoagulants Sales Market Share by Type (2015-2020)
Table 85. Latin America Injectable Anticoagulants Sales by Application (2015-2020) (K Units)
Table 86. Latin America Injectable Anticoagulants Sales Market Share by Application (2015-2020)
Table 87. Latin America Injectable Anticoagulants Sales by Countries (2015-2020) (K Units)
Table 88. Latin America Injectable Anticoagulants Sales Market Share by Countries (2015-2020)
Table 89. Latin America Injectable Anticoagulants Revenue by Countries (2015-2020) (Million US$)
Table 90. Latin America Injectable Anticoagulants Revenue Market Share by Countries (2015-2020)
Table 91. Middle East and Africa Injectable Anticoagulants Sales by Type (2015-2020) (K Units)
Table 92. Middle East and Africa Injectable Anticoagulants Sales Market Share by Type (2015-2020)
Table 93. Middle East and Africa Injectable Anticoagulants Sales by Application (2015-2020) (K Units)
Table 94. Middle East and Africa Injectable Anticoagulants Sales Market Share by Application (2015-2020)
Table 95. Middle East and Africa Injectable Anticoagulants Sales by Countries (2015-2020) (K Units)
Table 96. Middle East and Africa Injectable Anticoagulants Sales Market Share by Countries (2015-2020)
Table 97. Middle East and Africa Injectable Anticoagulants Revenue by Countries (2015-2020) (Million US$)
Table 98. Middle East and Africa Injectable Anticoagulants Revenue Market Share by Countries (2015-2020)
Table 99. Sanofi Company Details
Table 100. Sanofi Description and Business Overview
Table 101. Sanofi Injectable Anticoagulants Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Sanofi Injectable Anticoagulants Sales Growth Rate (2015-2020)
Table 103. Sanofi Injectable Anticoagulants Sales Market Share in Global Market
Table 104. Sanofi Recent Development
Table 105. Genentech (Roche) Company Details
Table 106. Genentech (Roche) Description and Business Overview
Table 107. Genentech (Roche) Injectable Anticoagulants Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Genentech (Roche) Injectable Anticoagulants Sales Growth Rate (2015-2020)
Table 109. Genentech (Roche) Injectable Anticoagulants Sales Market Share in Global Market
Table 110. Genentech (Roche) Recent Development
Table 111. Boehringer Ingelheim Company Details
Table 112. Boehringer Ingelheim Description and Business Overview
Table 113. Boehringer Ingelheim Injectable Anticoagulants Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 114. Boehringer Ingelheim Injectable Anticoagulants Sales Growth Rate (2015-2020)
Table 115. Boehringer Ingelheim Injectable Anticoagulants Sales Market Share in Global Market
Table 116. Boehringer Ingelheim Recent Development
Table 117. Pfizer Company Details
Table 118. Pfizer Description and Business Overview
Table 119. Pfizer Injectable Anticoagulants Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 120. Pfizer Injectable Anticoagulants Sales Growth Rate (2015-2020)
Table 121. Pfizer Injectable Anticoagulants Sales Market Share in Global Market
Table 122. Pfizer Recent Development
Table 123. The Medicines Company Company Details
Table 124. The Medicines Company Description and Business Overview
Table 125. The Medicines Company Injectable Anticoagulants Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 126. The Medicines Company Injectable Anticoagulants Sales Growth Rate (2015-2020)
Table 127. The Medicines Company Injectable Anticoagulants Sales Market Share in Global Market
Table 128. The Medicines Company Recent Development
Table 129. Aspen Company Details
Table 130. Aspen Description and Business Overview
Table 131. Aspen Injectable Anticoagulants Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 132. Aspen Injectable Anticoagulants Sales Growth Rate (2015-2020)
Table 133. Aspen Injectable Anticoagulants Sales Market Share in Global Market
Table 134. Aspen Recent Development
Table 135. Otsuka Company Details
Table 136. Otsuka Description and Business Overview
Table 137. Otsuka Injectable Anticoagulants Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 138. Otsuka Injectable Anticoagulants Sales Growth Rate (2015-2020)
Table 139. Otsuka Injectable Anticoagulants Sales Market Share in Global Market
Table 140. Otsuka Recent Development
Table 141. Injectable Anticoagulants Distributors List
Table 142. Injectable Anticoagulants Customers List
Table 143. Global Injectable Anticoagulants Sales Forecast 2021-2026 (K Units) & (Million US$)
Table 144. Global Injectable Anticoagulants Sales Forecast by Type 2021-2026 (K Units)
Table 145. Global Injectable Anticoagulants Sales Forecast by Application 2021-2026 (K Units)
Table 146. Global Injectable Anticoagulants Sales Forecast by Regions 2021-2026 (K Units)
Table 147. Global Injectable Anticoagulants Revenue Forecast by Regions 2021-2026 (Million US$)
Table 148. North America Injectable Anticoagulants Sales Forecast by Countries 2021-2026 (K Units)
Table 149. North America Injectable Anticoagulants Revenue Forecast by Countries 2021-2026
Table 150. Europe Injectable Anticoagulants Sales Forecast by Countries 2021-2026 (K Units)
Table 151. Europe Injectable Anticoagulants Revenue Market Share Forecast by Countries 2021-2026
Table 152. Asia Pacific Injectable Anticoagulants Sales Forecast by Regions 2021-2026 (K Units)
Table 153. Asia Pacific Injectable Anticoagulants Revenue Forecast by Regions 2021-2026 (Million US$)
Table 154. Latin America Injectable Anticoagulants Sales Forecast by Countries 2021-2026 (K Units)
Table 155. Latin America Injectable Anticoagulants Revenue Forecast by Countries 2021-2026 (Million US$)
Table 156. Middle East and Africa Injectable Anticoagulants Sales Forecast by Regions 2021-2026 (K Units)
Table 157. Middle East and Africa Injectable Anticoagulants Revenue Forecast by Regions 2021-2026 (Million US$)
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Injectable Anticoagulants Product Picture
Figure 2. Global Injectable Anticoagulants Sales Market Shar by Type 2015-2026
Figure 3. Low-molecular-weight Heparin (LMWH) Figures
Figure 4. Direct Thrombin Inhibitor (DTI) Figures
Figure 5. Other Figures
Figure 6. Global Injectable Anticoagulants Sales Market Share by Application in 2019 & 2026
Figure 7. VTE Use Case
Figure 8. ACS/MI Use Case
Figure 9. AF Use Case
Figure 10. Other Use Case
Figure 11. Injectable Anticoagulants Report Years Considered
Figure 12. Global Injectable Anticoagulants Market Size 2015-2026 (Million US$)
Figure 13. Global Injectable Anticoagulants Sales 2015-2020 (K Units)
Figure 14. Global Injectable Anticoagulants Market Size Market Share by Regions 2015-2020
Figure 15. Global Injectable Anticoagulants Sales Market Share by Regions in 2019
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Injectable Anticoagulants Sales Share by Manufacturers in 2019
Figure 18. The 5 and 10 Largest Manufacturers in the World: Market Share by Injectable Anticoagulants Sales in 2019
Figure 19. Injectable Anticoagulants Value Share by Manufacturers in 2019
Figure 20. Injectable Anticoagulants Revenue Share by Manufacturers In 2019
Figure 21. Injectable Anticoagulants Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Injectable Anticoagulants Revenue Share by Type (2015-2020)
Figure 23. Global Injectable Anticoagulants Revenue Growth Rate by Type in 2015 & 2019
Figure 24. Global Injectable Anticoagulants Market Share by Price Range (2015-2020)
Figure 25. Global Injectable Anticoagulants Revenue Share by Application (2015-2020)
Figure 26. Global Injectable Anticoagulants Revenue Growth Rate by Application in 2015 & 2019
Figure 27. North America Injectable Anticoagulants Revenue Growth Rate 2015-2020 (Million US$)
Figure 28. U.S. Injectable Anticoagulants Sales Growth Rate (2015-2020) (K Units)
Figure 29. Canada Injectable Anticoagulants Sales Growth Rate (2015-2020) (K Units)
Figure 30. Europe Injectable Anticoagulants Revenue Growth Rate 2015-2020 (Million US$)
Figure 31. Germany Injectable Anticoagulants Sales Growth Rate (2015-2020) (K Units)
Figure 32. France Injectable Anticoagulants Sales Growth Rate (2015-2020) (K Units)
Figure 33. U.K. Injectable Anticoagulants Sales Growth Rate (2015-2020) (K Units)
Figure 34. Italy Injectable Anticoagulants Sales Growth Rate (2015-2020) (K Units)
Figure 35. Russia Injectable Anticoagulants Sales Growth Rate (2015-2020) (K Units)
Figure 36. Asia Pacific Injectable Anticoagulants Revenue Growth Rate 2015-2020 (Million US$)
Figure 37. China Injectable Anticoagulants Sales Growth Rate (2015-2020) (K Units)
Figure 38. Japan Injectable Anticoagulants Sales Growth Rate (2015-2020) (K Units)
Figure 39. South Korea Injectable Anticoagulants Sales Growth Rate (2015-2020) (K Units)
Figure 40. India Injectable Anticoagulants Sales Growth Rate (2015-2020) (K Units)
Figure 41. Australia Injectable Anticoagulants Sales Growth Rate (2015-2020) (K Units)
Figure 42. Taiwan Injectable Anticoagulants Sales Growth Rate (2015-2020) (K Units)
Figure 43. Indonesia Injectable Anticoagulants Sales Growth Rate (2015-2020) (K Units)
Figure 44. Thailand Injectable Anticoagulants Sales Growth Rate (2015-2020) (K Units)
Figure 45. Malaysia Injectable Anticoagulants Sales Growth Rate (2015-2020) (K Units)
Figure 46. Philippines Injectable Anticoagulants Sales Growth Rate (2015-2020) (K Units)
Figure 47. Vietnam Injectable Anticoagulants Sales Growth Rate (2015-2020) (K Units)
Figure 48. Latin America Injectable Anticoagulants Revenue Growth Rate 2015-2020 (Million US$)
Figure 49. Mexico Injectable Anticoagulants Sales Growth Rate (2015-2020) (K Units)
Figure 50. Brazil Injectable Anticoagulants Sales Growth Rate (2015-2020) (K Units)
Figure 51. Argentina Injectable Anticoagulants Sales Growth Rate (2015-2020) (K Units)
Figure 52. Middle East and Africa Injectable Anticoagulants Revenue Growth Rate 2015-2020 (Million US$)
Figure 53. Turkey Injectable Anticoagulants Sales Growth Rate (2015-2020) (K Units)
Figure 54. Saudi Arabia Injectable Anticoagulants Sales Growth Rate (2015-2020) (K Units)
Figure 55. U.A.E Injectable Anticoagulants Sales Growth Rate (2015-2020) (K Units)
Figure 56. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Genentech (Roche) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. The Medicines Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Aspen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Otsuka Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Injectable Anticoagulants Value Chain
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Figure 66. North America Injectable Anticoagulants Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 67. North America Injectable Anticoagulants Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 68. Europe Injectable Anticoagulants Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 69. Europe Injectable Anticoagulants Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 70. Asia Pacific Injectable Anticoagulants Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 71. Asia Pacific Injectable Anticoagulants Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 72. Latin America Injectable Anticoagulants Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 73. Latin America Injectable Anticoagulants Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 74. Middle East and Africa Injectable Anticoagulants Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 75. Middle East and Africa Injectable Anticoagulants Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed


【掲載企業】

Sanofi、Genentech (Roche)、Boehringer Ingelheim、Pfizer、The Medicines Company、Aspen、Otsuka

★調査レポート[世界の注射用抗凝固剤市場:成長動向・競争分析2020-2026] (コード:QYR20AP01120)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の注射用抗凝固剤市場:成長動向・競争分析2020-2026]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆